Certain antiretroviral protease inhibitors (eg, atazanavir) used in the  treatment  of  the human immunodeficiency virus (HIV) infection can lead to increased levels of unconjugated hyperbilirubinaemia.


MoreVitaminovPRO ranked added it 2 years ago on Apr 8, 2019